For more information about this case, please contact
Berger & Montague, P.C. has extensive experience in securities litigation involving securities law violations regarding drugs and matters concerning Food and Drug Administration law and regulations, including a successful action for violation of the federal securities laws against ViroPharma concerning a drug under development that purportedly reduced the duration of the common cold, which was abandoned by the Company. Berger & Montague has also successfully litigated actions for violations of the securities laws against Nuvelo, Inc., Hemispherix Biopharma, CryoLife, Inc., Cephalon, Inc., Genentech, Inc., Sepracor, Inc., U.S. Bioscience, Synergen, Inc., Cryomedical Sciences, MediImmune, Inc., and Andrx Corp.
The firm was founded in 1970, is a pioneer in class action litigation. The firm's 70 attorneys concentrate their practice in complex litigation, including securities fraud, whistleblower and false claims actions and have recovered several billion dollars for consumers and investors.SOURCE Berger & Montague, P.C.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV